Cancer Immunotherapy

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease. Offers a synthesis of concepts that are useful to cancer immunologists and pharmacologists, who tend to work in disparate fields with little cross-communication Drs. Prendergast and Jaffee are internationally recognized leaders in cancer biology and immunology who have created a unique synthesis of fundamental and applied concepts in this important new area of cancer research Summarizes the latest insights into how immune escape defines an essential trait of cancer Includes numerous illustrations, including how molecular-targeted therapeutic drugs or traditional chemotherapy can be combined with immunotherapy to improve anti-tumor efficacy and how reversing immune suppression by the tumor can cause tumor regression

Produk Detail:

  • Author : George C. Prendergast
  • Publisher : Academic Press
  • Pages : 684 pages
  • ISBN : 0123946336
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKCancer Immunotherapy

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : George C. Prendergast,Elizabeth M. Jaffee
  • Publisher : Academic Press
  • Release : 04 June 2013
GET THIS BOOKCancer Immunotherapy

There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics

Immunotherapy

Immunotherapy
  • Author : Aung Naing,Joud Hajjar
  • Publisher : Springer Nature
  • Release : 16 April 2020
GET THIS BOOKImmunotherapy

Immunotherapy is a rapidly evolving field that mandates frequent revision of the book as new insights to fight cancer emerge. The third edition of Immunotherapy is an updated overview of immuno-oncology in different cancer types and toxicities associated with immunotherapy. It explores the breath of immunotherapeutic strategies available to treat a wide range of cancers, from melanoma and non-small cell lung cancer to gastrointestinal, genitourinary, gynecologic and nervous system malignancies. With increasing use of checkpoint inhibitors as standard of care

Vaccines for Cancer Immunotherapy

Vaccines for Cancer Immunotherapy
  • Author : Nima Rezaei,Mahsa Keshavarz-Fathi
  • Publisher : Academic Press
  • Release : 17 October 2018
GET THIS BOOKVaccines for Cancer Immunotherapy

Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the

The Basics of Cancer Immunotherapy

The Basics of Cancer Immunotherapy
  • Author : Haidong Dong,Svetomir N. Markovic
  • Publisher : Springer
  • Release : 05 January 2018
GET THIS BOOKThe Basics of Cancer Immunotherapy

This book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize

Translational Immunotherapy of Brain Tumors

Translational Immunotherapy of Brain Tumors
  • Author : John H. Sampson
  • Publisher : Academic Press
  • Release : 06 February 2017
GET THIS BOOKTranslational Immunotherapy of Brain Tumors

Translational Immunotherapy of Brain Tumors gives researchers and practitioners an up-to-date and comprehensive overview of the field. Chapters include adoptive immunotherapy, immunosuppression, CAR therapy of brain tumors, and dendritic cell therapy for brain tumors. Very few agents have been shown to be efficacious in the treatment of malignant gliomas. Recently, there have been a number of studies demonstrating the potential success of immunotherapy for brain tumors. Immunotherapeutics are becoming the most frequent drugs to be used in cancer therapy. These

Cancer Immunotherapy

Cancer Immunotherapy
  • Author : James P. Allison,Glenn Dranoff
  • Publisher : Academic Press
  • Release : 13 June 2021
GET THIS BOOKCancer Immunotherapy

For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic

Adoptive Immunotherapy

Adoptive Immunotherapy
  • Author : Burkhard Ludewig,Matthias W. Hoffmann
  • Publisher : Springer Science & Business Media
  • Release : 13 June 2021
GET THIS BOOKAdoptive Immunotherapy

Over the last decade, major advances in our understanding of the immune system and its mechanisms have led to promising new treatment strategies. In Adoptive Immunotherapy: Methods and Protocols, leading experts describe in detail their optimal techniques for producing and characterizing the immunologically active cells and effector molecules now gaining wide use in the clinical treatment of patients. Taking advantage of the latest technologies, the authors present readily reproducible experimental protocols for the study of dendritic cells, T-cells, monoclonal antibodies,

Brain Tumor Immunotherapy

Brain Tumor Immunotherapy
  • Author : Linda M. Liau,Donald P. Becker,Timothy F. Cloughesy,Darell D. Bigner
  • Publisher : Springer Science & Business Media
  • Release : 10 November 2000
GET THIS BOOKBrain Tumor Immunotherapy

An authoritative panel of researchers and clinicians critically reviews the entire field to provide a comprehensive guide to modern brain tumor immunotherapy and thereby enhance future research in this area. The contributors detail many of the key laboratory experiments and clinical protocols that are currently being investigated, integrate the available information from previous and ongoing research, and help define the current status of the field. Topics range from adoptive cellular and antibody-mediated immunotherapy of brain tumors to tumor vaccines and

Immunotherapy for Infectious Diseases

Immunotherapy for Infectious Diseases
  • Author : Jeffrey M. Jacobson
  • Publisher : Springer Science & Business Media
  • Release : 16 April 2002
GET THIS BOOKImmunotherapy for Infectious Diseases

In Immunotherapy for Infectious Disease, Jeffrey M. Jacobson, MD, and a panel of leading researchers review the state-of-the-art for treating various infections-particularly HIV-by manipulating the immune system's response rather than by chemical drugs. The contributors synthesize the principles of immune defense on the molecular level (monoclonal antibodies, vaccines, methods of antigen presentation, and cytokines and cytokine antagonists), as well as on the cellular and clinical levels levels as a protection against infection. The review of the current state of anti-HIV

Autophagy in Immune Response: Impact on Cancer Immunotherapy

Autophagy in Immune Response: Impact on Cancer Immunotherapy
  • Author : Salem Chouaib
  • Publisher : Academic Press
  • Release : 11 May 2020
GET THIS BOOKAutophagy in Immune Response: Impact on Cancer Immunotherapy

Autophagy in Immune Response: Impact on Cancer Immunotherapy focuses on the status and future directions of autophagy with respect to different aspects of its interaction with the immune system and immunotherapy. The book takes scientific research in autophagy a step further by presenting reputable information on the topic and offering integrated content with advancements in autophagy, from cell biology and biochemical research, to clinical treatments. This book is a valuable source for cancer researchers, oncologists, graduate students and several members

Immunotherapy of Cancer

Immunotherapy of Cancer
  • Author : Anonim
  • Publisher : Academic Press
  • Release : 29 July 2015
GET THIS BOOKImmunotherapy of Cancer

Immunotherapy of Cancer provides information on cancer research related to inflammation and immunity, containing outstanding reviews by experts in the field. It is suitable for researchers and students who have an interest in cancer immunobiology. Provides information on cancer research, including outstanding and original reviews Covers the current progress and emerging concepts in cancer inflammation, immunology, and immunotherapy Suitable for researchers and students studying, and interested in, the field of immunotherapy for cancer Ideal for those studying cancer inflammation, tumor

Cancer Active Immunotherapy

Cancer Active Immunotherapy
  • Author : G. Mathe
  • Publisher : Springer Science & Business Media
  • Release : 06 December 2012
GET THIS BOOKCancer Active Immunotherapy

I would like to thank all my co-workers who have collaborated with me, from 1963 until now, in biological and clinical research in the field of cancer active immunotherapy, of its immuno prevention and immunorestoration. They will often be quoted in this book. I am particularly grateful to those who have helped me to write it by reviewing some chapters: D. BELPOMME, J. F. DOR~, IRENE FLORENTIN, A. GOUTNER, I. J. Hm, R. HUCHET and MARIE-CHRISTINE SIMMLER. I also thank NICOLE

Cancer Immunology

Cancer Immunology
  • Author : Nima Rezaei
  • Publisher : Springer
  • Release : 24 April 2015
GET THIS BOOKCancer Immunology

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume focuses on the immunopathology and immunotherapy of organ cancers in detail. It clearly explains their immunology and describes novel immunotherapy for specific cancers, including pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, skin cancers, bone and connective tissue tumors, central nervous system tumors, lung cancers, genitourinary tract tumors and breast cancers. In so doing, it builds on the previous two volumes in Cancer Immunology,

Immunotherapy

Immunotherapy
  • Author : Aung Naing,Joud Hajjar
  • Publisher : Springer
  • Release : 29 December 2019
GET THIS BOOKImmunotherapy

The second edition of Immunotherapy is an updated overview of immuno-oncology in acute myleloid leukemia, non-small cell lung cancer and melanoma, showcasing advances in the management of cancer broadly classified as hematological malignancies and solid tumors. Though the spectrum of clinical activity and duration of response seen with these agents is promising, objective response is limited to a subset of patients and is often associated with distinct side effects that are potentially life-threatening. With increasing use of checkpoint inhibitors as